D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Comcast
CMCSA
|
+$346M |
| 2 |
Wells Fargo
WFC
|
+$285M |
| 3 |
IBM
IBM
|
+$264M |
| 4 |
Qualcomm
QCOM
|
+$252M |
| 5 |
Mondelez International
MDLZ
|
+$214M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$377M |
| 2 |
PayPal
PYPL
|
+$310M |
| 3 |
NVIDIA
NVDA
|
+$267M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$266M |
| 5 |
AABA
Altaba Inc. Common Stock
AABA
|
+$264M |
Sector Composition
| 1 | Technology | 17.21% |
| 2 | Healthcare | 12.97% |
| 3 | Consumer Discretionary | 12.74% |
| 4 | Financials | 10.33% |
| 5 | Communication Services | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Tejon Ranch
TRC
$451M
| $497K | ﹤0.01% |
24,238
-7,338
| -23% | -$150K |
|
|
BKCC
2027
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $496K | ﹤0.01% |
+66,149
| New | +$496K |
|
2028
Peoples Bancorp
PEBO
$1.09B
| $492K | ﹤0.01% |
14,662
-275
| -2% | -$9.23K |
|
|
RDC
2029
DELISTED
Rowan Companies Plc
RDC
| $492K | ﹤0.01% |
38,264
-540,115
| -93% | -$6.94M |
|
2030
Enova International
ENVA
$2.88B
| $490K | ﹤0.01% |
36,427
-16,217
| -31% | -$218K |
|
2031
NOV
NOV
$4.85B
| $489K | ﹤0.01% |
13,690
-2,787
| -17% | -$99.6K |
|
2032
Weis Markets
WMK
$1.73B
| $489K | ﹤0.01% |
+11,249
| New | +$489K |
|
|
HTB
2033
HomeTrust Bancshares, Inc.
HTB
$718M
| $489K | ﹤0.01% |
19,066
+2,069
| +12% | +$53.1K |
|
2034
Deluxe
DLX
$858M
| $484K | ﹤0.01% |
6,635
-35,673
| -84% | -$2.6M |
|
2035
Helen of Troy
HELE
$550M
| $483K | ﹤0.01% |
4,982
-6,995
| -58% | -$678K |
|
|
AUD
2036
DELISTED
Audacy, Inc.
AUD
| $482K | ﹤0.01% |
42,074
+26,349
| +168% | +$302K |
|
|
PX
2037
DELISTED
Praxair Inc
PX
| $482K | ﹤0.01% |
3,451
+325
| +10% | +$45.4K |
|
2038
CEVA Inc
CEVA
$549M
| $480K | ﹤0.01% |
11,214
+2,691
| +32% | +$115K |
|
2039
Fresh Del Monte Produce
FDP
$1.7B
| $479K | ﹤0.01% |
10,545
-13,318
| -56% | -$605K |
|
|
ADMS
2040
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $477K | ﹤0.01% |
+22,526
| New | +$477K |
|
|
AAIC
2041
DELISTED
Arlington Asset Investment Corp.
AAIC
| $474K | ﹤0.01% |
+37,264
| New | +$474K |
|
2042
The Ensign Group
ENSG
$9.59B
| $473K | ﹤0.01% |
22,404
-49,305
| -69% | -$1.04M |
|
2043
Veritex Holdings
VBTX
$1.87B
| $473K | ﹤0.01% |
+17,527
| New | +$473K |
|
|
BEAT
2044
DELISTED
BioTelemetry, Inc.
BEAT
| $471K | ﹤0.01% |
14,265
-77,644
| -84% | -$2.56M |
|
2045
Equity Bancshares
EQBK
$809M
| $469K | ﹤0.01% |
+13,176
| New | +$469K |
|
2046
Newell Brands
NWL
$2.54B
| $469K | ﹤0.01% |
+10,993
| New | +$469K |
|
2047
Axogen
AXGN
$739M
| $468K | ﹤0.01% |
+24,207
| New | +$468K |
|
|
HF
2048
DELISTED
HFF Inc.
HF
| $468K | ﹤0.01% |
11,819
-6,411
| -35% | -$254K |
|
|
GEN
2049
DELISTED
Genesis Healthcare, Inc.
GEN
| $466K | ﹤0.01% |
402,003
+40,641
| +11% | +$47.1K |
|
2050
Movado Group
MOV
$426M
| $464K | ﹤0.01% |
+16,572
| New | +$464K |
|